---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-156048"
form_type: "8-K"
ticker: "TNGX"
cik: "0001819133"
company_name: "Tango Therapeutics, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:59:15.656873+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Tango Therapeutics stockholders approve officer liability limit and elect directors at 2024 annual meeting

## Summary
- Shareholders approved amendment to Second Amended and Restated Certificate of Incorporation to limit officer liability under Delaware law (89.9M for, 5.5M against).
- Elected Alexis Borisy, John Ketchum, and Barbara Weber as Class III directors each with >90M votes for.
- Ratified PricewaterhouseCoopers as independent auditor for FY2024 (100.7M for, 2K against).
- Quorum of 94.35% (100.7M shares) present at virtual meeting.

## SEC filing metadata
- accession: 0001193125-24-156048
- form_type: 8-K
- ticker: TNGX
- cik: 0001819133
- company_name: Tango Therapeutics, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819133/000119312524156048/0001193125-24-156048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819133/000119312524156048/d768398d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-156048
- JSON: https://secwatch.observer/filing/0001193125-24-156048.json
- Plain text: https://secwatch.observer/filing/0001193125-24-156048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.